Back to Results
First PageMeta Content
Organic chemistry / Organofluorides / Anxiety disorders / Paroxetine / Piperidines / Antidepressant / Fluoxetine / Social anxiety disorder / GlaxoSmithKline / Psychiatry / Selective serotonin reuptake inhibitors / Chemistry


Template for Dear Health Care Professional Letters
Add to Reading List

Document Date: 2013-03-29 15:33:58


Open Document

File Size: 52,84 KB

Share Result on Facebook

City

Mississauga / OTTAWA / /

Company

GlaxoSmithKline Inc. / /

Country

United States / Italy / Israel / /

/

/

IndustryTerm

Internet access / non-pharmaceutical treatment / Healthcare professionals / teratogen information services / healthcare professionals advising / treatment of major depressive disorder / /

MedicalCondition

atrial septal defects / social anxiety disorder / major depressive disorder / panic disorder / posttraumatic stress disorder / Allergy / ventricular septal defects / anxiety disorder / premenstrual dysphoric disorder / obsessive-compulsive disorder / /

MedicalTreatment

cognitive behavioral therapy / surgery / /

Organization

Bureau of Cardiology / European Teratology Society / /

Person

John A Dillon / /

/

Position

MB BCh MFPM VP / Medical Division and Chief Medical Officer / /

Product

fluoxetine / PAXIL / PAXIL CR / /

ProvinceOrState

Ontario / /

Technology

html / /

URL

http /

SocialTag